Dermatitis News

Contact allergy to cardiac devices is not common but should be considered when there is concern for infection, a history of device extraction, a history of erythema at the implant site or negative culture results, according to a research letter.

Patients with atopic dermatitis who received baricitinib 4 mg plus a topical corticosteroid achieved 50% improvement in the Eczema Area and Severity Index score at week 16 at a significantly higher rate than patients who received placebo plus a topical corticosteroid, according to a study.

Dermatitis refers to various inflammations of the skin that occur in both children and adults. Some symptoms of dermatitis may overlap. The inflammation can be atopic, contact or seborrheic in nature but can also include mild conditions such as dandruff.

Faced with an increasing incidence and prevalence of autoimmune disease in the United States —approximately 23.5 million Americans are affected across the country, according to the NIH — Bonnie Feldman, MBA, DDS, says it is time to acknowledge what she calls “an invisible epidemic.”

New research on food allergy treatments, stewardship of oral corticosteroids, microbiome’s role in allergy development, and shared decision making were some of the highlights at the recent American Academy of Allergy, Asthma and Immunology annual meeting. 

Mothers who exclusively breastfed for longer than 3 months significantly lowered their child’s risk of eczema, according to findings presented at the American Academy of Allergy, Asthma and Immunology Annual Meeting.

A “statistically significant” proportion of adult patients using Olumiant for moderate to severe atopic dermatitis had clearer skin vs. those using placebo in two phase 3 studies evaluating its efficacy and safety, according to a press release from Eli Lilly and Co.

The prevalence of active atopic eczema is high among older adults and increases with age, according to research published in Annals of Internal Medicine.

Eating fast foods, particularly hamburgers, three or more times a week correlated to asthma in a dose-response pattern, according to a systematic review recently published in Respirology.

Sanofi and Regeneron’s drug Dupixent led to clearer skin in most patients in phase 3 trial involving 12- to 17-year-olds with moderate-to-severe atopic dermatitis, according to a press release from the company.